MOLINA ARTURO MD

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 66% 68% 82%
Transactions
15 7% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
MOLINA ARTURO MD's trades of Protagonist Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
260.43
Quantity 49,531
Value US$1,364,071
Transaction date
Proposed sale
Price
435.83
Quantity 57,517
Value US$3,929,483
Transaction date
Proposed sale
Price
83.42
Quantity 13,151
Value US$1,097,116
Transaction date
Proposed sale
Price
55.00
Quantity 30,514
Value US$1,678,270
Transaction date
Purchase
Price
7.75
Quantity 6,451 +114.5%
Value US$49,995
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-27 2026-03-26
S Sale
8,253 -28.2%
368.31
US$4,863,568 		8,253 -28.2% 368.31 US$4,863,568
2026-03-26 2026-03-26
PrS Proposed sale
49,531
260.43
US$1,364,071 		49,531 260.43 US$1,364,071
2026-01-27 2026-01-27
PrS Proposed sale
57,517
435.83
US$3,929,483 		57,517 435.83 US$3,929,483
2026-01-27 2026-01-27
S Sale
5,000 -5.6%
82.00
US$410,000 		5,000 -5.6% 82.00 US$410,000
2026-01-27 2026-01-26
S Sale
5,000 -5.6%
82.28
US$411,400 		5,000 -5.6% 82.28 US$411,400
2026-01-26 2026-01-26
PrS Proposed sale
5,000
82.28
US$411,396 		5,000 82.28 US$411,396
2026-01-27 2026-01-23
S Sale
13,151 -13.5%
82.42
US$1,083,905 		13,151 -13.5% 82.42 US$1,083,905
2026-01-23 2026-01-23
PrS Proposed sale
13,151
83.42
US$1,097,116 		13,151 83.42 US$1,097,116
2026-01-21 2026-01-20
PrS Proposed sale
9,514
82.48
US$784,715 		9,514 82.48 US$784,715
2026-01-21 2026-01-20
S Sale
9,514 -8.9%
82.48
US$784,715 		9,514 -8.9% 82.48 US$784,715
2025-11-19 2025-11-17
S Sale
2,712 -3.2%
84.77
US$229,896 		2,712 -3.2% 84.77 US$229,896
2025-06-11 2025-06-10
S Sale
10,000 -10.7%
57.03
US$570,300 		10,000 -10.7% 57.03 US$570,300
2025-06-10 2025-06-10
PrS Proposed sale
10,000
57.03
US$570,269 		10,000 57.03 US$570,269
2025-06-11 2025-06-09
S Sale
10,000 -10.7%
55.51
US$555,100 		10,000 -10.7% 55.51 US$555,100
2025-06-09 2025-06-09
PrS Proposed sale
10,000
55.51
US$555,077 		10,000 55.51 US$555,077
2025-03-14 2025-03-13
S Sale
30,514 -26.7%
55.74
US$1,700,850 		30,514 -26.7% 55.74 US$1,700,850
2025-03-13 2025-03-13
PrS Proposed sale
30,514
55.00
US$1,678,270 		30,514 55.00 US$1,678,270
2024-11-27 2024-11-27
PrS Proposed sale
16,000
44.00
US$704,000 		16,000 44.00 US$704,000
2024-11-27 2024-11-27
S Sale
16,000 -25.6%
44.83
US$717,280 		16,000 -25.6% 44.83 US$717,280
2024-11-27 2024-11-27
S Sale
10,000 -17.7%
44.50
US$445,000 		10,000 -17.7% 44.50 US$445,000
2024-11-27 2024-11-26
S Sale
5,529 -10.6%
45.60
US$252,122 		5,529 -10.6% 45.60 US$252,122
2024-11-26 2024-11-26
PrS Proposed sale
16,000
45.00
US$720,000 		16,000 45.00 US$720,000
2024-11-19 2024-11-15
S Sale
1,906 -3.9%
40.98
US$78,108 		1,906 -3.9% 40.98 US$78,108
2024-01-04 2023-11-15
S Sale
1,848 -7.6%
16.24
US$30,012 		1,848 -7.6% 16.24 US$30,012
2020-05-14 2020-05-14
B Purchase
6,451 +114.5%
7.75
US$49,995 		6,451 +114.5% 7.75 US$49,995